Yoshie Umemura

8PUBLICATIONS
151CO-AUTHORS
Predictive and prognostic markersGenomics and transcriptomicsMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 12, 2025
Prognostic Features of Recurrent Midline and H3 K27M-Mutant Glioma.

Stephen J Bagley, Yoshie Umemura, Joe S Mendez

|Feb 13, 2025
Robust Cluster Prediction Across Data Types Validates Association of Sex and Therapy Response in GBM.

David L Gibbs, Gino Cioffi, Boris Aguilar

|Apr 09, 2024
Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.

Monica F Chen, Zihe Song, Helena A Yu

|Oct 30, 2023
GTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress.

Weihua Zhou, Zitong Zhao, Angelica Lin

|Aug 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji

|Nov 17, 2022
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphoma.

Anna M Laucis, Katherine Selwa, Yilun Sun

Pageof 2

Frequent Collaborators

2 joint publications

Daniel Wahl

2 joint publications

Costas A Lyssiotis

2 joint publications

Erik R Peterson

2 joint publications

Yazmin Odia